Olfaction in aging and Alzheimer's disease: Event-related potentials to a cross-modal odor-recognition memory task discriminate ApoE ε4+ and ApoE ε4- individuals

Annals of the New York Academy of Sciences

Volumn 1170, Issue , 2009, Pages 647-657

  Murphy, Claire ^a,b   Solomon, Ethan S ^a   Haase, Lori ^a,b   Wang, Miran ^a   Morgan, Charlie D ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Alzheimer's disease; ApoE 4; Olfaction; Olfactory impairment; Recognition memory; Smell

Indexed keywords

APOLIPOPROTEIN E4;

AGED; AGING; ALLELE; ALZHEIMER DISEASE; BRAIN NERVE CELL; CELL POPULATION; COGNITION; CONFERENCE PAPER; CONTROLLED STUDY; ELECTRODE; ELECTROENCEPHALOGRAM; ELECTROPHYSIOLOGY; EVENT RELATED POTENTIAL; FEMALE; HUMAN; LATENT PERIOD; MALE; MEMORY; NERVOUS TISSUE; OLFACTORY DISCRIMINATION; SMELLING;

EID: 68649125846     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04486.x     Document Type: Conference Paper

References (75)

1. Hebert, L.E. et al. 2003. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch. Neurol. 60: 1119-1122.
2. Farrer, L.A. et al. 1995. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives. Ann. Neurol. 38: 797-808.
3. Mayeux, R. 2003. Epidemiology of neurodegeneration. Annu. Rev. Neurosci. 26: 81-104.
4. Mortimer, J.A., D.A. Snowdon & W.R. Markesbery. 2003. Head circumference, education and risk of dementia: findings from the Nun Study. J. Clin. Exp. Neuropsychol. 25: 671-679.
5. Jellinger, K.A. 2004. Head injury and dementia. Curr. Opin. Neurol. 17: 719-723.
6. Motte, J. & R.S.Williams. 1989. Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain. Acta Neuropathol. 77: 535-546.
7. Wisniewski, K.E., H.M. Wisniewski & G.Y. Wen. 1985. Occurrence of neuropathological changes and dementia of Alzheimer's disease inDown's syndrome. Ann. Neurol. 17: 278-282.
8. Raber, J., Y. Huang & J.W. Ashford. 2004. ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol. Aging 25: 641- 650.
9. Farrer, L.A. et al. 1997. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278: 1349-1356.
10. Corder, E.H. et al. 1995. The apolipoprotein E E4 allele and sex-specific risk of Alzheimer's disease. JAMA 273: 373-374.
11. Namba, Y. et al. 1991. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541: 163-166.
12. Saunders, A.M. et al. 1993. Apolipoprotein E epsilon 4 allele distributions in late-onset alzheimer's disease and in other amyloid-forming diseases. Lancet 342: 710-711.
13. Das, H.K. et al. 1985. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J. Biol. Chem. 260: 6240- 6247.
14. Olaisen, B., P. Teisberg & T. Gedde-Dahl, Jr. 1982. The locus for apolipoprotein E (apoE) is linked to the complement component C3 (C3) locus on chromosome 19 in man. Hum. Genet. 62: 233-236.
15. Poirier, J. et al. 1993. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342: 697- 699.
16. Strittmatter, W.J. et al. 1993. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 1977- 1981.
17. Poirier, J. 1994. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17: 525-530.
18. Tapiola, T. et al. 1998. CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease. Neurology 50: 169-174.
19. Soininen, H.S. & P.J. Riekkinen, Sr. 1996. Apolipoprotein E, memory and Alzheimer's disease. Trends Neurosci. 19: 224-228.
20. Feskens, E.J. et al. 1994. Apolipoprotein e4 allele and cognitive decline in elderly men. BMJ 309: 1202- 1206.
21. Haan,M.N. et al. 1999.The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 282: 40-46.
22. Hyman, B.T. et al. 1996. Apolipoprotein E and cognitive change in an elderly population. Ann. Neurol. 40: 55-66.
23. Jonker, C. et al. 1998. Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Arch. Neurol. 55: 1065-1069.
24. Yaffe, K. et al. 1997. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. Arch. Neurol. 54: 1110-1114.
25. Riley, K.P. et al. 2000. Cognitive function and apolipoprotein E in very old adults: findings from the Nun Study. J. Gerontol. B Psychol. Sci. Soc. Sci. 55: S69-S75.
26. Carmelli, D. et al. 2000. The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function. J. Gerontol. A Biol. Sci. Med. Sci. 55: M103- M109.
27. Staehelin, H.B. et al. 1999. Apolipoprotein E genotypes and cognitive functions in healthy elderly persons. Acta Neurol. Scand. 100: 53-60.
28. Henderson, A.S. et al. 1995. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample. Lancet 346: 1387-1390.
29. O'Hara, R. et al. 1998. The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults. J. Am. Geriatr. Soc. 46: 1493-1498.
30. Small, B.J., H. Basun & L. Backman. 1998. Threeyear changes in cognitive performance as a function of apolipoprotein E genotype: evidence from very old adults without dementia. Psychol. Aging 13: 80-87.
31. Brayne, C. et al. 1996. Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population. Dementia 7: 169-174.
32. Helkala, E.L. et al. 1996.Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study. Neurosci. Lett. 204: 177-180.
33. Braak, H. & E. Braak. 1997. Staging of Alzheimerrelated cortical destruction. Int. Psychogeriatr. 9(Suppl 1): 257-261; discussion 269-272.
34. Price, J.L. et al. 1991. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol. Aging 12: 295-312.
35. Esiri, M.M. & G.K. Wilcock. 1984. The olfactory bulbs in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 47: 56-60.
36. Bacon, A.W. et al. 1998. Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction. Ann. N. Y. Acad. Sci. 855: 723-731.
37. Murphy, C. et al. 1990. Olfactory thresholds are associated with degree of dementia in Alzheimer's disease. Neurobiol. Aging 11: 465-469.
38. Nordin, S. & C. Murphy. 1996. Impaired sensory and cognitive olfactory function in questionable Alzheimer's disease. Neuropsych. 10: 112-119.
39. Serby M. 1986. Olfaction and Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 10: 579-586.
40. Doty R.L. et al. 1991. Odor identification deficit of the parkinsonism-dementia complex of Guam: equivalence to that of Alzheimer's and idiopathic Parkinson's disease. Neurology 5(Suppl 2): 77-80; discussion 80-81.
41. Morgan, C.D., S. Nordin & C. Murphy. 1995. Odor identification as an early marker for Alzheimer's disease: impact of lexical functioning and detection sensitivity. J. Clin. Exp. Neuropsychol. 17: 793-803.
42. Murphy, C., A. Bacon, M.W. Bondi & D.P. Salmon. 1998. Apolipoprotein E status is associated with odor identification deficits in nondemented older persons. Ann. N. Y. Acad. Sci. 855: 744-750.
43. Murphy, C., S. Nordin & S. Jinich. 1999. Very early decline in recognition memory for odors in Alzheimer's disease. Aging Neuropsychol. Cogn. 6: 229- 240.
44. Schiffman S.S., B.G. Graham, E.A. Sattely-Miller, et al. 2002. Taste, smell and neuropsychological performance of individuals at familial risk for Alzheimer's disease. Neurobiol. Aging 23: 397-404.
45. Bacon, A.W., J.S. Paulsen & C.Murphy. 1999. A test of odor fluency in patients with Alzheimer's disease and Huntington's chorea. J. Clin. Exp. Neuropsychol. 21: 341-351.
46. Morgan, C.D. & C. Murphy. 2002. Olfactory eventrelated potentials in Alzheimer's disease. J. Int. Neuropsychol. Soc. 8: 753-763. 46a.Wilson, R.S., S.E. Arnold, J.A. Schneider, et al. 2009. Olfactory impairment in presymptomatic Alzheimer's disease. Ann. N. Y. Acad. Sci. International Symposium on Olfaction and Taste. 1170: 730-735.
47. Yamagishi, M. et al. 1998. Increased density of olfactory receptor neurons immunoreactive for apolipoprotein E in patients with Alzheimer's disease. Ann. Otol. Rhinol. Laryngol. 107: 421-426.
48. Calhoun-Haney, R. & C. Murphy. 2005. Apolipoprotein epsilon4 is associated with more rapid decline in odor identification than in odor threshold or Dementia Rating Scale scores. Brain Cogn. 58: 178- 182.
49. Craik, F.I.M. & R.S. Lockhart. 1972. Levels of processing: a framework for memory research. J. Verb. Learn. Verb. Behav. 11: 671-684.
50. Stark, C.E. & L.R. Squire. 2000. Functional magnetic resonance imaging (fMRI) activity in the hippocampal region during recognition memory. J. Neurosci. 20: 7776-7781.
51. Morcom, A.M. & M.D. Rugg. 2002. Getting ready to remember: the neural correlates of task set during recognition memory. Neuroreport 13: 149-152.
52. Gilbert, P.E. & C. Murphy. 2004. The effect of the ApoE epsilon4 allele on recognition memory for olfactory and visual stimuli in patients with pathologically confirmed Alzheimer's disease, probable Alzheimer's disease, and healthy elderly controls. J. Clin. Exp. Neuropsychol. 26: 779-794.
53. Nordin, S. & C. Murphy. 1998. Odor memory in normal aging andAlzheimer's disease. Ann. N. Y. Acad. Sci. 855: 686-693.
54. Sundermann, E.E., P.E. Gilbert & C.Murphy. 2007. Apolipoprotein E epsilon4 genotype and gender: effects onmemory. Am. J.Geriatr. Psychiatry 15: 869-878.
55. Bondi, M.W. et al. 1995. Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults. Neurology 45: 2203-2206.
56. Morgan, C.D. et al. 1997. Olfactory event-related potentials: oldermales demonstrate the greatest deficits. Electroencephalogr. Clin. Neurophysiol. 104: 351-358.
57. Murphy, C. et al. 1994. Olfactory-evoked potentials: assessment of young and elderly, and comparison to psychophysical threshold. Chem. Senses 19: 47-56.
58. Donchin, E. & M.G. Coles. 1988. Is the P300 component a manifestation of context updating? Behav. Brain Sci. 11: 357-427.
59. Polich, J. 1998. P300 clinical utility and control of variability. J. Clin. Neurophysiol. 15: 14-33.
60. Geisler, M.W. et al. 1999. Neuropsychological performance and cognitive olfactory event-related brain potentials in young and elderly adults. J. Clin. Exp. Neuropsychol. 21: 108-126.
61. Kramer, A.F. & D.L. Strayer. 1988. Assessing the development of automatic processing: an application of dual-task and event-related brain potential methodologies. Biol. Psychol. 26: 231-267.
62. Wickens, C. et al. 1983. Performance of concurrent tasks: a psychophysiological analysis of the reciprocity of information-processing resources. Science 221: 1080-1082.
63. Morgan, C.D. et al. 1999. Olfactory P3 in young and older adults. Psychophysiology 36: 281-287.
64. Murphy, C. et al. 2000. Olfactory event-related potentials and aging: normative data. Int. J. Psychophysiol. 36: 133-145.
65. Wetter, S. & C. Murphy. 2001. Apolipoprotein E epsilon4 positive individuals demonstrate delayed olfactory event-related potentials. Neurobiol. Aging 22: 439-447.
66. Cerf-Ducastel, B. & C. Murphy. 2006. Neural substrates of cross-modal olfactory recognition memory: an fMRI study. NeuroImage 31: 386-396.
67. Murphy, C. et al. 2002. Prevalence of olfactory impairment in older adults. JAMA 288: 2307-2312.
68. Murphy, C., S. Nordin & L. Acosta. 1997. Odor learning, recall, and recognition memory in young and elderly adults. Neuropsychology 11: 126- 137.
69. Mattis, S. 1988. Dementia Rating Scale: Professional manual. Psychological Assessment Resources. Odessa, FL.
70. Folstein, M.F., S.E. Folstein & P.R. McHugh. 1975. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12: 189-198.
71. Semlitsch, H.V. et al. 1986. A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP. Psychophysiology 23: 695-703.
72. Green, J. & A.I. Levey. 1999. Event-related potential changes in groups at increased risk for Alzheimer disease. Arch. Neurol. 56: 1398-1403.
73. Geroldi, C. et al. 1999. APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology 53: 1825-1832.
74. Rosso, S.M. et al. 2002.Apolipoprotein E4 in the temporal variant of frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 72: 820.
75. Gilbert, P.E. & C. Murphy. 2004. Differences between recognition memory and remote memory for olfactory and visual stimuli in nondemented elderly individuals genetically at risk for Alzheimer's disease. Exp. Gerontol. 39: 433-441.